Role of 5-hydroxytryptamine3 (5-HT3) antagonists in the prevention of emesis caused by anticancer therapy.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Biochemical Pharmacology

• Publication date

  1996-09-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0006-2952(96)00346-2PMID 8765466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjects

  2004cited by this paper
• TWO KINDS OF TRYPTAMINE RECEPTOR

  1997cited by this paper
• Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients.

  1995cited by this paper
• 5‐HT3 Receptor‐independent Inhibition of the Depolarization‐induced 86Rb Efflux from Human Neuroblastoma Cells, TE671, by Ondansetron

  1995cited by this paper
• Differential inhibition of stress-induced adrenocortical responses by 5-HT1A agonists and by 5-HT2 and 5-HT3 antagonists.

  1995cited by this paper
• The physiology and pharmacology of postoperative nausea and vomiting

  1994cited by this paper
• Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret.

  1994cited by this paper
• The 5-hydroxytryptamine receptor antagonists as antiemetics: preclinical evaluation and mechanism of action.

  1993cited by this paper
• Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo.

  1993cited by this paper
• Urinary serotonin metabolite excretion during cisplatin chemotherapy

  1993cited by this paper
• A proposed new nomenclature for 5-HT receptors.

  1993cited by this paper
• Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties.

  1993cited by this paper
• Pharmacology and preclinical antiemetic properties of ondansetron.

  1992cited by this paper
• Mechanisms by which cancer chemotherapeutic drugs induce emesis.

  1992cited by this paper
• Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists.

  1992cited by this paper
• Central and peripheral 5-HT3 receptors

  1992cited by this paper
• Age and gender effects on ondansetron pharmacokinetics: Evaluation of healthy aged volunteers

  1992cited by this paper
• Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694).

  1991cited by this paper
• The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom control.

  1991cited by this paper
• Activation and desensitization of the 5‐HT3 receptor in a rat glioma x mouse neuroblastoma hybrid cell.

  1991cited by this paper
• Differentiation of NG108-15 cells alters channel conductance and desensitization kinetics of the 5-HT3 receptor.

  1991cited by this paper
• Properties of 5‐hydroxytryptamine3 receptor‐gated currents in adult rat dorsal root ganglion neurones

  1991cited by this paper
• Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel.

  1991cited by this paper
• Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics.

  1991cited by this paper
• 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study.

  1991cited by this paper
• Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.

  1991cited by this paper
• Physicochemical Properties of Serotonin 5‐HT3 Binding Sites Solubilized from Membranes of NG 108‐15 Neuroblastoma‐Glioma Cells

  1990cited by this paper
• Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.

  1990cited by this paper
• Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

  1990cited by this paper
• Ion permeation through 5-hydroxytryptamine-gated channels in neuroblastoma N18 cells

  1990cited by this paper
• Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem

  1990cited by this paper
• Solubilisation of the 5‐Hydroxytryptamine3 Receptor from Pooled Rat Cortical and Hippocampal Membranes

  1990cited by this paper
• The role of receptor subtype diversity in the CNS.

  1990cited by this paper
• Serotonin raises the cyclic GMP level in a neuronal cell line via 5-HT3 receptors.

  1989cited by this paper
• 5-HT3 receptors are membrane ion channels

  1989cited by this paper
• Serotonin regulates cytosolic Ca2+ activity and membrane potential in a neuronal and in a glial cell line via 5-HT3 and 5-HT2 receptors by different mechanisms.

  1989cited by this paper
• Electrophysiology of 5-HT3 receptors in neuronal cell lines.

  1989cited by this paper
• The 5-HT3 receptor ligand, [3H]BRL 43694, binds to presynaptic sites in the nucleus tractus solitarius of the rat.

  1989cited by this paper
• Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.

  1989cited by this paper
• Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting.

  1989cited by this paper
• The properties of 5‐HT3 receptors in clonal cell lines studied by patch‐clamp techniques

  1989cited by this paper
• Blockade of 5-hydroxytryptamine3 receptors prevents cisplatin-induced but not motion- or xylazine-induced emesis in the cat.

  1989cited by this paper
• 5‐HT3 receptor antagonists injected into the area postrema inhibit cisplatin‐induced emesis in the ferret

  1989cited by this paper
• Identification and Characterisation of 5‐Hydroxytryptamine3 Recognition Sites in Human Brain Tissue

  1989cited by this paper
• Zacopride, a potent 5‐HT3 antagonist

  1988cited by this paper
• Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.

  1988cited by this paper
• Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells.

  1988cited by this paper
• A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930.

  1988cited by this paper
• Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors

  1988cited by this paper
• The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.

  1988cited by this paper
• Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.

  1988cited by this paper
• Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930

  1988cited by this paper
• The pharmacology and function of 5-HT3receptors

  1986cited by this paper
• Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum

  1985cited by this paper
• Discrete lesions of the area postrema abolish radiation-induced emesis in the dog.

  1985cited by this paper
• Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs

  1985cited by this paper
• Neuronal 5-HT receptors in the periphery.

  1984cited by this paper
• Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.

  1981cited by this paper
• An Apomorphine‐Induced Vomiting Model for Antiemetic Studies in Man

  1978cited by this paper

• Evaluation of the Cardiovascular and Serotonergic Modulatory Effects of Ondansetron in Healthy Dogs Under Anesthesia.

  2026cites this paper
• Vortioxetine derivatives with amino acid as promoiety: synthesis, activity, stability and preliminary pharmacokinetic study.

  2021cites this paper
• Molecular Pharmacology of Phytocannabinoids.

  2017cites this paper
• The 5-HT3 Receptor Antagonist Ondansetron Attenuates Pancreatic Injury in Cerulein-Induced Acute Pancreatitis Model

  2017cites this paper
• Phytocannabinoids: Unraveling the Complex Chemistry and Pharmacology of Cannabis sativa

  2017cites this paper
• Tests for Anxiolytic Activity

  2015cites this paper
• The relationship between perioperative nausea and vomiting and serum serotonin concentrations in patients undergoing cesarean section under epidural anesthesia

  2014cites this paper
• The Pyrrole Etomidate Analog Carboetomidate Potently Inhibits Human 5-HT3A Receptor Function: Comparisons with Etomidate and Potential Implications for Emetogenesis

  2013cites this paper
• A Review On: Recent Advancement of Stomach Specific Floating Drug Delivery System

  2011cites this paper
• The acute effects of ondansetron on the electrocardiogram in clinically normal dogs

  2010cites this paper
• Association of 5-HT 3A receptor Pro16Ser polymorphism with the incidence of PONV and the response to ondansetron in Korean patients

  2008cites this paper
• The Effects of Fentanyl-Like Opioids and Hydromorphone on Human 5-HT3A Receptors

  2008cites this paper
• Muscularis mucosae - the forgotten sibling.

  2007cites this paper
• Advances in the Understanding and Treatment of Depression and its Physical Symptoms

  2007cites this paper
• Effects of Ondansetron and Granisetron on Rocuronium-induced Neuromuscular Blockade in a Rat Phrenic Nerve-hemidiaphragm Preparation

  2006cites this paper
• Structure-based 3D-QSAR studies on thiazoles as 5-HT3 receptor antagonists

  2006cites this paper
• The Effects of Morphine on Human 5-HT3A Receptors

  2006cites this paper
• Synthesis and biological evaluation of a novel structural type of serotonin 5-HT3 receptor antagonists.

  2006cites this paper
• Microwave-assisted solvent-free synthesis of 3-[(4-substituted piperazin-1-yl)alkyl] imidazo[2,1-b][1,3]benzothiazol-2(3H)-ones as serotonin3 (5-HT3) receptor antagonists.

  2005cites this paper
• WIN 55,212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT(3) receptor function.

  2005cites this paper
• Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.

  2005cites this paper
• Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile as a new class of serotonin 5-HT3 receptor antagonists.

  2004cites this paper
• Influence of sodium substitutes on 5‐HT‐mediated effects at mouse 5‐HT3 receptors

  2004cites this paper
• Cannabinoid receptor‐independent inhibition by cannabinoid agonists of the peripheral 5‐HT3 receptor‐mediated von Bezold–Jarisch reflex

  2003cites this paper
• Effect of Ginseng Saponins on the Recombinant Serotonin Type 3A Receptor Expressed in Xenopus Oocytes: Implication of Possible Application as an Antiemetic

  2003cites this paper
• Direct inhibition by cannabinoids of human 5‐HT3A receptors: probable involvement of an allosteric modulatory site

  2002cites this paper
• Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis

  2001cites this paper
• Modified 5-HT3A receptor function by co-expression of alternatively spliced human 5-HT3A receptor isoforms

  2000cites this paper
• Exon-intron organization of the human 5-HT3A receptor gene.

  2000cites this paper
• Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.

  2000cites this paper
• A multivariate analysis for predicting cisplatin-induced delayed emesis.

  2000cites this paper
• Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride

  1999cites this paper
• Anticancer therapy-induced emesis: existence of an intestinal subtype of the 5-HT3 receptor?

  1998cites this paper
• Psychotropic and neurotropic activity

  1997cites this paper
• Chemotherapy.

  1997cites this paper
• Dolasetron. A new 5-hydroxytryptamine3 receptor antagonist.

  1997cites this paper